Hamilton, United Kingdom

Ian C Carlyle

This inventor holds 5 USPTO granted patents. Top assignees: Akzo N.v., Akzona Incorporated. Active years: 1980-1995.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 35(Granted Patents)


Company Filing History:


Years Active: 1980-1995

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Ian C Carlyle: Innovator in Neuromuscular Blocking Derivatives

Introduction

Ian C Carlyle is a notable inventor based in Hamilton, GB. He has made significant contributions to the field of neuromuscular blocking agents, holding a total of 5 patents. His work has advanced the understanding and application of various chemical compounds in medical science.

Latest Patents

Carlyle's latest patents include innovative compounds such as Monoquaternary 2,16-bispiperidinylandrostane derivatives. These neuromuscular blocking derivatives are characterized by the formula: ##STR1##, wherein R.sub.1 is ethyl. Another significant patent is for Novel 2.beta.-morpholino-androstane derivatives, which are compounds defined by the formula: ##STR1##, where R.sub.1 can be H or an optionally substituted acyl group containing 1-12 carbon atoms.

Career Highlights

Throughout his career, Ian C Carlyle has worked with prominent companies such as Akzo N.V. and Akzona Incorporated. His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of chemistry and pharmacology.

Collaborations

Carlyle has collaborated with notable colleagues, including Thomas Sleigh and David S Savage. These partnerships have contributed to the successful development of his patented compounds.

Conclusion

Ian C Carlyle's contributions to the field of neuromuscular blocking agents through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the medical and scientific communities.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…